Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary

Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary

Item
http://www.wikidata.org/entity/Q33564586
A community consultation survey to evaluate support for and success of the IMMEDIATE trial.One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment anOut-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study,,TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction.In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial.Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study.Patients' views of consent for research enrollment during acute myocardial infarction.Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.Genetic variation at glucose and insulin trait loci and response to glucose–insulin–potassium (GIK) therapy: the IMMEDIATE trial
P2860

Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary

Item
http://www.wikidata.org/entity/Q33564586
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Study design for the Immediate ...... d potassium for acute coronary
@ast
Study design for the Immediate ...... d potassium for acute coronary
@en
Study design for the Immediate ...... d potassium for acute coronary
@nl
type
label
Study design for the Immediate ...... d potassium for acute coronary
@ast
Study design for the Immediate ...... d potassium for acute coronary
@en
Study design for the Immediate ...... d potassium for acute coronary
@nl
prefLabel
Study design for the Immediate ...... d potassium for acute coronary
@ast
Study design for the Immediate ...... d potassium for acute coronary
@en
Study design for the Immediate ...... d potassium for acute coronary
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Study design for the Immediate ...... d potassium for acute coronary
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932